Triple

T5873325
Position Surface form Disambiguated ID Type / Status
Subject Paediatric Regulation E130568 entity
Predicate requires P100 FINISHED
Object Paediatric Investigation Plan for new indications E130568 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Paediatric Investigation Plan for new indications | Statement: [Paediatric Regulation, requires, Paediatric Investigation Plan for new indications]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Paediatric Investigation Plan for new indications
Context triple: [Paediatric Regulation, requires, Paediatric Investigation Plan for new indications]
  • A. Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
    The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • B. Conditional Marketing Authorization by European Medicines Agency
    Conditional Marketing Authorization by the European Medicines Agency is a fast-track regulatory pathway that allows earlier approval of medicines, such as COVID-19 vaccines, based on less comprehensive data than normally required, provided that the benefits outweigh the risks and additional data will be supplied post-approval.
  • C. Paediatric Regulation chosen
    The Paediatric Regulation is a European Union law designed to improve the development and availability of medicines specifically adapted for use in children.
  • D. Certificates of Suitability to the monographs of the European Pharmacopoeia
    Certificates of Suitability to the monographs of the European Pharmacopoeia are official documents issued by the European Directorate for the Quality of Medicines & HealthCare (EDQM) confirming that a substance’s quality complies with the relevant European Pharmacopoeia monograph, thereby simplifying regulatory approval for medicines across Europe.
  • E. Clinical Practices of the University of Pennsylvania
    Clinical Practices of the University of Pennsylvania is the faculty practice plan and outpatient clinical arm of Penn Medicine, providing patient care across a wide range of specialties in collaboration with the University of Pennsylvania’s health system.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085047dc8190af24e311edad3c07 completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c035f99b788190b5b06d83b9499bfa completed March 22, 2026, 6:33 p.m.
NED1 Entity disambiguation (via context triple) batch_69c0b11b48d88190ba6cd5ade2f47a89 completed March 23, 2026, 3:18 a.m.
Created at: March 22, 2026, 3:57 p.m.